Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE S3 ( December, 2021 ) > List of Articles

INVITED ARTICLE

Liver Diseases in the Parturient

Sridhar Sundaram, Suprabhat Giri

Keywords : Acute fatty liver of pregnancy, Cholestasis of pregnancy, Hemolysis, elevated liver enzymes, and low platelets syndrome, Pregnancy

Citation Information :

DOI: 10.5005/jp-journals-10071-24027

License: CC BY-NC 4.0

Published Online: 12-01-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

PDF Share
  1. Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol 2016;64(4):933–945. DOI: 10.1016/j.jhep.2015.11.030.
  2. Goel A, Jamwal KD, Ramachandran A, Balasubramanian KA, Eapen CE. Pregnancy-related liver disorders. J Clin Exp Hepatol 2014;4(2):151–162. DOI: 10.1016/j.jceh.2013.03.220.
  3. Fell DB, Dodds L, Joseph KS, Allen VM, Butler B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol 2006;107(2 Pt 1):277–284. DOI: 10.1097/01.AOG.0000195059.82029.74.
  4. Koot MH, Grooten IJ, van der Post JAM, Bais JMJ, Ris-Stalpers C, Leeflang MMG, et al. Determinants of disease course and severity in hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 2020;245:162–167. DOI: 10.1016/j.ejogrb.2019.12.021.
  5. Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. J Matern Fetal Neonatal Med 2018;31(18):2492–2505. DOI: 10.1080/14767058.2017.1342805.
  6. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15(17):2049–2066. DOI: 10.3748/wjg.15.2049.
  7. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004;40(2):467–474. DOI: 10.1002/hep.20336.
  8. Kong X, Kong Y, Zhang F, Wang T, Yan J. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: a meta-analysis (a prisma-compliant study) [published correction appears in Medicine (Baltimore) 2017;96(3):e6031]. Medicine (Baltimore) 2016;95(40):e4949. DOI: 10.1097/MD.0000000000004949.
  9. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 2014;4(2):97–104. DOI: 10.1016/j.preghy.2014.02.001.
  10. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103(5 Pt 1):981–991. DOI: 10.1097/01.AOG.0000126245.35811.2a.
  11. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 2009;9:8. DOI: 10.1186/1471-2393-9-8.
  12. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195(4):914–934. DOI: 10.1016/j.ajog.2005.08.044.
  13. Greenstein D, Henderson JM, Boyer TD. Liver hemorrhage: recurrent episodes during pregnancy complicated by preeclampsia. Gastroenterology 1994;106(6):1668–1671. DOI: 10.1016/0016-5085(94)90425-1.
  14. Naoum EE, Leffert LR, Chitilian HV, Gray KJ, Bateman BT. Acute fatty liver of pregnancy: pathophysiology, anesthetic implications, and obstetrical management. Anesthesiology 2019;130(3):446–461. DOI: 10.1097/ALN.0000000000002597.
  15. Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006;107(1):115–120. DOI: 10.1097/01.AOG.0000191297.47183.bd.
  16. Morton A, Laurie J. Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy. Obstet Med 2018;11(3):126–131. DOI: 10.1177/1753495X18759353.
  17. Westbrook RH, Yeoman AD, Joshi D, Heaton ND, Quaglia A, O'Grady JG, et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant 2010;10(11):2520–2526. DOI: 10.1111/j.1600-6143.2010.03301.x.
  18. Licata A, Ingrassia D, Serruto A, Soresi M, Giannitrapani L, Montalto G, et al. Clinical course and management of acute and chronic viral hepatitis during pregnancy. J Viral Hepat 2015;22(6):515–523. DOI: 10.1111/jvh.12335.
  19. Chaudhry SA, Koren G. Hepatitis A infection during pregnancy. Can Fam Physician 2015;61(11):963–964. PMID: 26881283.
  20. Singh S, Mohanty A, Joshi YK, Dwivedi SN, Deka D. Outcome of hepatitis E virus infection in Indian pregnant women admitted to a tertiary care hospital. Indian J Med Res 2001;113:35–39. PMID: 21910283.
  21. Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy?Am J Gastroenterol 2008;103(10):2495–2501. DOI: 10.1111/j.1572-0241.2008.02032.x.
  22. Mortele KJ, Barish MA, Yucel KE. Fulminant herpes hepatitis in an immunocompetent pregnant woman: CT imaging features. Abdom Imaging 2004;29(6):682–684. DOI: 10.1007/s00261-004-0199-y.
  23. Ren W, Li X, Jia J, Xia Y, Hu F, Xu Z. Prevalence of Budd-Chiari syndrome during pregnancy or puerperium: a systematic review and meta-analysis. Gastroenterol Res Pract 2015;2015:839875. DOI: 10.1155/2015/839875.
  24. Ingraham CR, Padia SA, Johnson GE, Easterling TR, Liou IW, Kanal KM, et al. Transjugular intrahepatic portosystemic shunt placement during pregnancy: a case series of five patients. Cardiovasc Intervent Radiol 2015;38(5):1205–1210. DOI: 10.1007/s00270-015-1053-z.
  25. Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl 2008;14(8):1081–1091. DOI: 10.1002/lt.21572.
  26. de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63(3):743–752. DOI: 10.1016/j.jhep.2015.05.022.
  27. Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology 2014;60(3):954–963. DOI: 10.1002/hep.27006.
  28. Giles M, Visvanathan K, Lewin S, Bowden S, Locarnini S, Spelman T, et al. Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut 2014;64(11):1810–1815. DOI: 10.1136/gutjnl-2014-308211.
  29. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67(4):1560–1599. DOI: 10.1002/hep.29800.
  30. Snijdewind IJ, Smit C, Schutten M, Nellen FJ, Kroon FP, Reiss P, et al. Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected mothers. J Clin Virol 2015;68:11–15. DOI: 10.1016/j.jcv.2015.04.002.
  31. Westbrook RH, Yeoman AD, Kriese S, Heneghan MA. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 2012;38(2–3):J239–J244. DOI: 10.1016/j.jaut.2011.12.002.
  32. Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006;101(3):556–560. DOI: 10.1111/j.1572-0241.2006.00479.x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.